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AbstrAct
Introduction: About 15% of patients diagnosed with type 1 diabetes might also suffer from celiac disease. Celiac 
disease accompanying type 1 diabetes may lead to the incidence of hypoglycaemia or ketoacidosis and increased 
risk of complications such as retinopathy and osteoporosis. 
Aim of the study: An analysis of the case of a patient suffering from type 1 diabetes and celiac disease and the 
presentation of a nursing care plan. 
Material and methods: The study describes the case of an 18-year-old female patient who had just been diagnosed 
with type 1 diabetes and celiac and was hospitalised in September 2017. The information about her medical history 
and condition was obtained by means of an interview, observation, and analysis of medical records with the applica-
tion of a survey questionnaire, the Visual Analogue Scale (VAS), and the Acceptance of Illness Scale (AIS).
Case description and analysis: The main problems of the patient were connected with celiac symptoms: acute diar-
rhoea, calf cramps, and overweight caused by dietary mistakes. The patient’s deficit of knowledge about dietary 
procedures had a negative impact on her somatic and mental condition. According to the AIS scale, the patient 
showed a moderate acceptance towards her illness (a score of 35).
Conclusions: Nursing care provided to patients diagnosed with type 1 diabetes and celiac disease should aim at 
recognising knowledge and skill deficits, education, and emotional support. Patients’ failure to follow dietary recom-
mendations, nutritional deficiencies, and incorrect eating habits frequently result not only from an unwillingness 
to change eating habits but also from low quality of consumed gluten-free products.
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IntroductIon
The importance of genetic factors in type 1 
diabetes and celiac disease
Type 1 diabetic patients are often at risk of devel-
oping asymptomatic celiac disease. The concomitance 
of diabetes and celiac disease is determined to a large 
extent by genetic factors. HLA-DR3-DQ8 and DR4-DQ8 
holotypes are characteristic for type 1 diabetes. In ce-
liac disease, on the other hand, HLA-DR3 and HLA-B8 
antigens and HLA-DQA1 and HLA-DQ2 alleles and gen-
otypes are the dominant ones. DR3-DQ2 holotypes ap-
pear in 80-90% of celiac patients, and in the case of 
diabetic patients the risk of the incidence of gluten-sen-
sitive enteropathy increases by as much as 33% [1-3]. 
The analyses that have been conducted so far are 
not unanimous as far as the number of adults and 
children diagnosed with diabetes and celiac disease 
is concerned [4, 5]. Gluten-sensitive enteropathy in 
type  1 diabetes is more common in women than in 
men: 99% and 16.7%, respectively. The symptoms usu-
ally appear between the ages of 10 and 45 years, and 
late diagnosis results from the latent form of the dis-
ease. An overt form of celiac disease appears in 13% 
of patients on average. The basic symptom of the con-
comitance of celiac disease in the case of type 1 dia-
betes is instability in blood glucose level and difficulty 
in stabilising it. Lack of proper diagnostic procedures 
and treatment as well as ignoring symptoms lead to 
the development of diabetic complications such as 
nephropathy and retinopathy, or celiac complications 
such as osteoporosis. Proper diet not only reduces the 
112
Anna Piskorz, Katarzyna Rogowska, Renata Wolfshaut-Wolak, Iwona Oskędra
Nursing Problems 2/2020 
risk of these complications but also minimises the 
risk of death caused by concomitant diseases, which 
is three times higher than in the case of patients who 
suffer from diabetes only [1].
Dietary procedures in type 1 diabetes  
and celiac disease 
Patients suffering from type 1 diabetes and celiac 
disease should introduce some changes into their 
diet, which are complex and difficult to apply in prac-
tice. A gluten-free diet has a big impact on the control 
of blood glucose level. According to the research con-
ducted in 2016 by Swensson et al., a well-balanced 
gluten-free diet may result in lowering the level of 
glycated haemoglobin by 21% and decreasing the 
amount of the insulin taken by a patient [6].
Research into dietary treatment applied in dia-
betes proved that the effects of blood glucose level 
control were better in the case of patients follow-
ing a  well-balanced diet based on the glycaemic 
index (GI) than in the case of patients applying car-
bohydrate exchanges [7]. The glycaemic index (GI) is 
a classification of food products according to their im-
pact on blood glucose level and the time after which 
this effect can be observed (meal tolerance test). 
Food products can be divided into three groups: low 
GI foods < 55%, medium GI foods 55-70%, and high 
GI foods > 70%. The glycaemic index of gluten and 
gluten-free products is affected by numerous factors 
such as the amount and type of carbohydrates, food 
preparation method, the degree of food fragmenta-
tion or degradation of cell membrane structures, and 
even the degree of fruit ripeness [8]. After an analysis 
of 12 studies, which examined 612 patients diagnosed 
with type 1 and 2 diabetes, Thomas et al. proved that 
lower GI values of food products consumed by pa-
tients (GI ranging from 38 to 77%) resulted in more 
efficient control of blood glucose level, which was as-
sessed based on the concentration of of HbA1c and 
fructosamine in the serum [7].
In the case of concomitance of diabetes and celiac 
disease there are problems connected with high GI 
values and low residue mass of gluten-free products, 
which are digested and absorbed much faster. Glu-
ten-free products are produced with the application 
of starches containing much more amylopectin than 
amylose, which accounts for their alpha-amylase di-
gestion and high GI values. In order to slow down 
the digestion process it is necessary to introduce to 
this diet fibre products dedicated to celiac patients 
or guar, which, thanks to its gelating properties, sig-
nificantly impedes digestion, speeds up the intestinal 
passage, and thus shortens the time of absorption of 
metabolic products [9]. 
The study conducted by Segura et al. on the rate 
of in vitro starch hydrolysis showed that the starch 
from gluten-free products is usually hydrolysed very 
rapidly, and GI values of gluten-free bread analysed 
in the study were very high, ranging from 83.3% to 
96% [10]. In order to enrich gluten-free bread made 
mostly from corn flour and rice flour, so-called pseu-
docereals including amaranth and buckwheat are 
used in bread baking. They raise the content of min-
erals, fats, and proteins in products made from so-
called European cereals, which are devoid of nutri-
tional value because of the refining process. Another 
procedure that may increase the content of proteins, 
fats, and minerals in gluten-free bread is the applica-
tion in its production of 30% lupin flour [9].
The Agency for Healthcare Research and Quality 
at the U.S. Department of Health and Human Services 
recommends that a gluten-free diet should be based 
on wholemeal and enriched cereal products, wild rice, 
and pseudocereals such as amaranth, manioc, millet, 
quinoa, sorghum, or teff. In turn, the Sydney Universi-
ty Glycaemic Index Research Service (SUGiRS) recom-
mends that low glycaemic index should be the main 
criterion for choosing food products in the case of 
a gluten-free diet, and it recommends introducing le-
guminous vegetables and products made from them 
to meals as well as eating low-fat yoghurts. Fruits 
growing in temperate climate such as apples, pears, 
peaches, plums, and apricots are appropriate in this 
diet because of their low glycaemic index and pectin 
content. Due to their low carbohydrate content, leafy 
greens such as cabbage, lettuce, spinach, cauliflower, 
and broccoli should be preferred, whereas the intake 
of root vegetables such as potatoes, sweet potatoes, 
taro, or yam should be reduced [11]. 
A group of studies into nutritional deficiencies ad-
dresses another problem of a diet therapy. In as many 
as 30% of celiac patients were shown to have pro-
tein, vitamin, or mineral deficiencies, which resulted 
from absorption disorders, an imbalanced gluten-free 
diet, or low quality of gluten-free products (high GI, 
high content of added sugars and saturated fatty 
acids, low content of fibre and minerals) [12]. The 
most frequent problems were calcium (Ca), iron (Fe), 
and magnesium (Mg) deficiencies (because in the 
course of chronic hyperglycaemia these elements are 
excessively lost with the urine), and vitamin B
12
 and 
folic acid shortages [13, 14]. 
In the initial treatment of celiac disease the risk 
of secondary lactose intolerance must be taken into 
account, especially in patients who suffer from acute 
diarrhoea caused by the damage of intestinal villi. In 
this case a lactose-free diet should be introduced for 
two or three months [15]. Numerous studies carried 
out among children, teenagers, and adults suffering 
from type 1 diabetes and celiac disease indicate fre-
quent occurrence of overweight and obesity in this 
group of patients [16, 17]. Nursing type 1 diabetic 
patients with concomitant celiac disease requires 
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AIm of the study
An analysis of the case of a patient suffering from 
type 1 diabetes and celiac disease, and the presenta-
tion of a nursing care plan.
mAterIAl And methods 
The study describes the case of an 18-year-old 
female patient who had just been diagnosed with 
type 1 diabetes and celiac disease. The study applied 
the method of a case study and the following research 
techniques: an interview, observation, and analysis 
of medical records. The research tools applied in the 
study included a self-designed questionnaire, the Ac-
ceptance of Illness Scale (AIS), and the Visual Ana-
logue Scale (VAS). The survey questionnaire made 
it possible to analyse the somatic condition of the 
patient including basic life parameters and anthropo-
metric measurements such as height and weight, and 
to calculate body mass index. 
 The Acceptance of Illness Scale was used to as-
sess to what extent the patient accepted her condi-
tion. The scale consists of eight statements that de-
scribe a possible negative attitude to the illness. The 
patient’s task was to describe her current condition 
on a  five-point Likert scale. The patient may score 
between the minimum score of 8 and the maximum 
score of 40, where 36-40 denotes a high level of ac-
ceptance, 20-35 – an average level of acceptance, and 
8-19 – a low level of acceptance. The higher the score, 
the better the patient can adapt to the limitations re-
sulting from their current health condition [20].
The Visual Analogue Scale is a  reliable measure 
to assess the patient’s intensity of pain, which allows 
for the assessment of the efficiency of pain therapy. 
The scale has a form of a 10-centimetre ruler. Patients 
show with their finger or a slider the intensity of pain, 
where 0 means no pain, and 10 – the worst pain pos-
sible [21].
The study was carried out in September 2017 in 
the Specialist Hospital in Krakow. The study received 
the approval of the hospital authorities. It was con-
ducted during five meetings lasting one hour each. 
The patient was informed about the aim and form of 
the study. The patient gave her informed consent to 
participate in the study. 
cAse study
The subject of the study was an 18-year-old fe-
male patient. The respondent lived with her mother 
in a city in the Małopolska region. She was a third-
year high school student. The patient was physically 
fit and independent in everyday life. She was admit-
ted to a  local hospital in the city in which she lived 
because of a fainting episode which resulted from hy-
perglycaemia. Due to the lack of a specialist diabetic 
a  complex assessment of their health needs. These 
patients not only need emotional support but also 
reliable information provided by medical staff, includ-
ing nurses, about how they should act and what is 
important in the treatment of type 1 diabetes and 
celiac disease, as well as some instructions on what 
they can expect during the progress of their disease. 
In order to improve the quality of patients’ health and 
life it is essential that they cooperate with a dietician 
on a proper nutrition plan [12, 18]. 
Education is the most important element in 
diabetic and celiac therapy. It involves promoting 
a healthy lifestyle, appropriate choice of food prod-
ucts, and self-care skills including elements of phar-
macotherapy. Developing new skills and acquiring 
knowledge about the disease give patients the sense 
of control over their life and treatment as well as the 
sense of security and increased quality of life. A dia-
betic patient is looked after by a variety of special-
ists. The therapeutic team consists of a doctor, dieti-
cian, physiotherapist, psychologist, and a nurse who 
is the team leader because of her/his professional 
competences and the frequency of contact with the 
patient. As the leader of the education process, the 
nurse should provide patients and their families with 
basic knowledge so that they could understand im-
portant recommendations concerning self-care in 
their condition and could apply them in practice. 
It is important to use appropriate vocabulary and 
teaching materials, and to adjust the pace and the 
amount of information to patients’ intellectual ca-
pacity. It is vital to include in the educational process 
the definition and aetiology of type 1 diabetes and 
celiac disease as well as information on treatment 
methods including insulin therapy, measuring blood 
glucose level, the importance of physical activity, 
ways of dealing with the incidence of hypoglycaemia 
or hyperglycaemia, and the choice of food products 
for diabetic and celiac patients and the methods of 
preparing them [18]. As far as dietary treatment is 
concerned, nurses are obliged to discuss the role of 
particular nutrients and give appropriate examples. 
They should provide patients with information about 
the importance of regular meals, the role of dietary 
fibre, and the necessity to eliminate from their diet 
products with high glycaemic index or including glu-
ten. Moreover, patients should be informed about 
the correlation between the blood glucose level and 
the quality of physical activity. The training should 
be prepared beforehand taking into account patients’ 
diagnosis as well as the objectives of undertaken ac-
tions and a treatment plan. It seems vital to assess 
the extent to which the patients reach educational 
goals. Patients’ education is a long-term process be-
cause the acquired information must be completed 
and updated along with the advances in medical 
technology and pharmacology [19].
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tient’s blood glucose level during her hospitalisation. 
The data show a  significant fluctuation of glucose 
concentration as the blood glucose level measured 
in the morning and before meals exceeded recom-
mended values of 70-110 mg/dl. Moreover, a  high 
concentration of blood glucose was observed early 
in the morning (a phenomenon known as the dawn 
effect). Such a phenomenon is typical of type 1 dia-
betes patients, especially in adolescence. It results 
from an increased production of growth hormone by 
the pituitary gland, which takes place at night [22]. 
Medical records and an interview with the patient 
showed that during the previous few weeks she had 
experienced episodes of hypoglycaemia about two 
times a  week, including hand tremors, hot flushes, 
and weakness. Additionally, for the last three months 
the patient had been complaining of diarrhoea and 
nocturnal calf cramps. The patient was advised to 
do a serological test. The further diagnostic process 
showed the presence of HLA-DRB1*04.DQ8 haplo-
type, which increases the risk of celiac disease.
Assessment of patient’s condition
The assessment of the patient’s bio-psycho-social 
condition was conducted on the basis of an interview, 
physical examination, and anthropometric measure-
ments. The following observations were made: 
1. Respiratory system: Inaudible breathing through 
the nose, thoracic respiration with the rate of 
16 breaths per minute. The patients did not report 
any respiratory issues. 
2. Digestive system: Height: 165 cm, weight: 80 kg, 
body mass index (BMI): 29.38 kg/m2, overweight, 
periodic diarrhoea, normal appetite. The patient 
had insufficient knowledge about proper nutrition 
in diabetes and celiac disease. The patient com-
plained of stomach aches that appeared about 
30 minutes after a meal. She suffered from diar-
rhoea with three to five loose stools a day. 
ward the patient was referred to another hospital. 
The study started on the fourth day of the patient’s 
hospitalisation. 
Data obtained from the interview  
and medical records
The data connected with type 1 diabetes refer to 
the preceding six months. The patient complained 
of periodic dizziness, lapses of concentration, and 
tiredness. In the previous year she had fainted twice 
during her school classes. These episodes made her 
mother decide that the patient should see the doctor. 
A blood glucose test was taken, and the fasting 
glucose level reached 166 mg/dl (9.22 mmol/l). An-
other blood glucose test also exceeded the accept-
able range. In September 2017 the patient was re-
ferred to a  diabetology clinic for further diagnosis. 
The result of an oral glucose tolerance test (OGTT) 
test taken two hours after drinking glucose solution 
reached 220 mg/dl (12.2 mmol/l) and confirmed dia-
betes. In the same month, the patient was admitted 
to the Specialist Hospital and treated on the ward 
of Metabolic Diseases and Diabetology. During the 
treatment both the patient and her mother partici-
pated in a series of standard training sessions within 
the School for Diabetics programme, which were run 
by a team of medical professionals including a doctor, 
a nurse, and a dietician. The training addressed the 
problem of measuring blood glucose levels and their 
interpretation, rules of insulin administering, dietary 
recommendations appropriate for type 1 diabetes and 
celiac disease treatment, and preparing an individual 
nutrition plan. 
The patient was treated with insulin therapy with 
the application of a  rapid acting insulin analogue 
(NovoRapid) and long-acting analogue (Levemir). The 
medicine dosage was prescribed by a doctor taking 
into account a  full profile of the patient’s glucose 
blood level. Table 1 presents a full profile of the pa-
Table 1. Glycaemic profile of the examined patient during hospitalisation
First day  
of hospitalisation
Second day  
of hospitalisation
Third day  
of hospitalisation





8:30 a.m. – 198 mg/dl 
(before breakfast)
11:00 a.m. – 240 mg/dl
1:00 p.m. – 195 mg/dl
3:00 p.m. – 254 mg/dl
5:00 p.m. – 176 mg/dl
7:30 p.m. – 240 mg/dl
9:00 p.m. – 210 mg/dl
12.00 midnight – 
187 mg/dl
3:30 a.m. – 298 mg/dl
6:00 a.m. – 214 mg/dl
8:30 a.m. – 150 mg/dl
11:00 a.m. – 244 mg/dl
1:00 p.m. – 190 mg/dl
3:00 p.m. – 234 mg/dl
5:00 p.m. – 153 mg/dl
7:30 p.m. – 211 mg/dl
9:00 p.m. – 190 mg/dl
12:00 midnight – 
140 mg/dl
3:30 a.m. – 132 mg/dl
6:00 a.m. – 126 mg/dl
8:30 a.m. – 122 mg/dl
11:00 a.m. – 210 mg/dl
1:00 p.m. – 63 mg/dl
3:00 p.m. – 202 mg/dl
5:00 p.m. – 140 mg/dl
7:30 p.m. – 200 mg/dl
9:00 p.m. – 127 mg/dl
12:00 midnight – 
103 mg/dl
3:30 a.m. – 98 mg/dl
6:00 a.m. – 88 mg/dl
8:30 a.m. – 80 mg/dl
11:00 a.m. – 160 mg/dl
1:00 p.m. – 112 mg/dl
3:00 p.m. – 135 mg/dl
5:00 p.m. – 100 mg/dl
7:30 p.m. – 134 mg/dl
9:00 p.m. – 106 mg/dl
12:00 midnight – 
110 mg/dl
3:30 a.m. – 100 mg/dl
8:30 a.m. – 89 mg/dl
11:00 a.m. – 140 mg/dl
3:00 p.m. – 138 mg/dl
7:30 p.m. – 122 mg/dl
11:00 a.m., 3:00 p.m., 7:30 p.m. – 2 hours after the main meal
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3. Cardiovascular system: Blood pressure taken on 
right arm was 128/76 mmHg and on the left arm 
– 124/70 mmHg; strong, firm, and regular pulse 
with 78 heat beats per minute measured on radial 
artery.
4. Genitourinary system: The patient did not report 
any complaints connected with the urinary system. 
Regular menstruation, first menstrual period at 
the age of 12 years. The patient was not pregnant. 
5. Locomotor system: The patient was independent 
in everyday routines. She did not take up any 
physical activity apart from school PE lessons. 
She reported periodic nocturnal lower leg cramps. 
The intensity of pain during the cramp was as-
sessed by the patient as 3 on the VAS scale.
6. Nervous system: The patient was conscious, in 
logical contact with her environment, and aware 
of the place and time. No pathologies were ob-
served in her nervous system. 
7. Skin: Clear, elastic, and dry. No disturbing skin dis-
orders were observed.
8. Sensory nervous system: No abnormalities were 
observed in the patient. 
9. Acceptance of illness: The patient’s score and 
the AIS was 35, which means that she accepted 
her health condition to a  moderate extent. The 
patient was concerned about dietary limitations 
connected with type 1 diabetes and celiac disease. 
10. Pharmacological treatment: The patient was 
treated with a rapid-acting insulin analogue and 
in the evening with a  long-acting analogue ad-
ministered in the form of subcutaneous injec-
tions. Oral painkillers were also prescribed in the 
case of pain. In order to keep the patient hydrated 
isoionic and isotonic multi-electrolyte fluid IV and 
NaCl 0.9% were prescribed. 
Table 2 presents a nursing plan. 
dIscussIon
The concomitance of diabetes and celiac disease 
is determined to a  large extent by genetic factors. 
As many as 80-90% of celiac patients have holotype 
DR3-DQ2, and, in the case of diabetic patients, this 
holotype increases the risk of the incidence of gluten-
sensitive enteropathy by up to 33%. Type 1 diabetes is 
a very important risk factor that leads to the develop-
ment of celiac disease in children and young people. 
The presence of haplotype HLA-DRB1*04.DQ8 predis-
posing to the incidence of celiac disease was also con-
firmed in the case of the patient [1-3]. 
The incidence rate in the group of type 1 diabe-
tes patients approximates 5-8%, and it is higher than 
in the general population [22]. About 16% of children 
suffering from type 1 diabetes have serological mark-
ers of celiac diseases: anti-endomysial antibodies 
or tissue transglutaminase antagonists [23]. In the 
studies conducted in a  group of children and teen-
agers suffering from type 1 diabetes, celiac disease 
was found in 2.2-15.1% of cases, which is 20 times 
more frequently than in the case of the diabetes-free 
population [24, 25]. Surveillance studies conducted in 
European countries and in North America proved that 
in a group of diabetic children and teenagers, celiac 
disease was diagnosed simultaneously with type  1 
diabetes or within a year from diabetic diagnosis in 
60% of respondents. In the other 40% of cases ce-
liac disease was diagnosed within 24-36 months af-
ter diabetic diagnosis [25]. The studies on the con-
comitance of celiac disease carried out in a  group 
of adult type 1 diabetic patients led to conflicting 
results. Some studies conducted in a group of adult 
type 1 diabetic patients showed that celiac disease 
was recognised two times less frequently than in the 
case of children and teenagers. On the other hand, 
other studies proved that celiac disease is concomi-
tant with type 1 diabetes to the same extent as in 
the case of children and teenagers, that is in about 
12.3-13.8% of patients [3, 26].
Recommendations of the Polish Diabetes Asso-
ciation on diabetic care for children and teenagers 
issued in 2019 focus only on diagnosing celiac dis-
ease according to ESPGHAN guidelines, and if no 
symptoms are observed within the first 10 years of 
diabetes, screening tests are recommended every or 
every other year. However, there are no similar recom-
mendations as far as adults are concerned [27, p. 63]. 
Concomitant asymptomatic celiac disease and type 1 
diabetes in adult patients is a  clinical problem that 
is rarely taken into consideration. Moreover, compli-
cated and costly diagnostics frequently accounts for 
a delayed diagnosis of celiac disease in adult patients 
suffering from type 1 diabetes. Every form of celiac 
disease might have a significant impact on the course 
of diabetes and the prognosis for patients’ life expec-
tancy and quality [26].
The examined case of a young patient diagnosed 
with type 1 diabetes and celiac disease proves that 
patients suffering from autoimmune disorders are 
also likely to suffer from concomitant celiac disease, 
especially when the clinical picture indicates the in-
cidence of diarrhoea; this was also confirmed by the 
studies conducted by Bardella et al. [26].
The treatment plan of the examined diabetic and 
celiac patient should take into account the possibil-
ity of eating several gluten-free meals accompanied 
by a dose of rapid-acting analogue. Such a scheme 
prevents sudden hypo- and hyperglycaemia incidents, 
especially during the period of celiac diagnosis. The 
aforementioned scheme of therapeutic procedures is 
also confirmed by the study conducted by Galicka-
Latała et al. [28].
Numerous studies on new methods of treating celi-
ac disease have appeared recently, but these methods 
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are still in their experimental stage. Nowadays a proper 
gluten-free diet remains the recommended form of ce-
liac treatment. The findings of the latest studies show 
that patients often have problems with recognising 
gluten sources and unknowingly exceed the accept-
able daily intake of this protein. It involves the risk of 
numerous complications including osteoporosis, mal-
occlusion, angular cheilitis, liver functional disorders, 
or even tumours – small-intestinal adenocarcinoma, 
mouth cancer, oesophageal cancer, duodenal cancer, 
or colon cancer [29]. Numerous studies conducted in 
celiac patients confirm that excess weight and obe-
sity are observed both at the time of the diagnosis and 
while following a  gluten-free diet. After a  two-year 
therapy there was a marked increase in patients’ BMI 
values – from 24.4 to 25.9 kg/m2 [16, 30]. 
In the examined case the main task of a nurse was 
to educate the patient and her family on the aetiology 
of type 1 diabetes and celiac disease, insulin thera-
py, measuring blood glucose level, the importance of 
physical activity, ways of dealing with the incidence 
of hypoglycaemia or hyperglycaemia, and the choice 
of food products for diabetic and celiac patients. The 
patient was a young person who found it difficult to 
follow new medical recommendations. The informa-
tive and emotional support of the nursing staff was 
extremely important for this young patient. It de-
creased her anxiety resulting from dietary restrictions. 
Another important aspect that allowed for a positive 
prognosis for the patient was her acceptance of illness 
determined by means of AIS scale. The patient’s com-
plaints were connected mainly with celiac symptoms 
(stomach ache and diarrhoea), overweight, deficient 
knowledge about nutrition in type 1 diabetes and ce-
liac disease, and lack of self-care skills.
conclusIons 
Diet therapy plays an important role in the treat-
ment of type 1 diabetes and celiac disease. In the 
case of patients suffering from both type 1 diabetes 
and celiac disease, following a  proper diet requires 
special dietary consultations, an enormous patients’ 
involvement and an ability to balance a diet. 
Patients’ failure to follow dietary recommenda-
tions, nutritional deficiencies, and bad eating habits 
(excess weight, obesity) frequently result not only 
from their lack of acceptance of the disease and un-
willingness to change their eating habits, but also 
from low quality of consumed gluten-free products.
The educational and supportive role of a  nurse 
as well as her or his professional and individual ap-
proach to the patient contribute to an improvement 
in the patient’s somatic and psychological condition.
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